共 23 条
- [1] AHMANN DL, 1966, CANCER-AM CANCER SOC, V19, P461, DOI 10.1002/1097-0142(196604)19:4<461::AID-CNCR2820190402>3.0.CO
- [2] 2-X
- [4] The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1100 - 1118
- [5] Eich HT, 2008, STRAHLENTHER ONKOL, V184, P406, DOI 10.1007/s00066-008-1882-7
- [8] Role of FDG-PET in the Implementation of Involved-Node Radiation Therapy for Hodgkin Lymphoma Patients [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (05): : 1047 - 1052
- [10] Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 40 - 45